SCHEMBL316330

SCHEMBL316330

C=CC(C)CCCC(C)CCCC(C)C

nearest known ligand 0.59

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.59
MEN1 O00255 1/20 0.52
CYP3A4 P08684 1/20 0.52
ALOX15 P16050 1/20 0.52
KMT2A Q03164 1/20 0.52
BLM P54132 1/20 0.43
PTPN1 P18031 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4227180 1.00 LMNA (0.59) LMNAMEN1CYP3A4ALOX15KMT2A
SCHEMBL11683348 0.93 LMNA (0.56) LMNAMEN1CYP3A4ALOX15KMT2A
SCHEMBL4905354 0.93 LMNA (0.46) LMNAMEN1CYP3A4ALOX15KMT2A
SCHEMBL670979 0.93 LMNA (0.46) LMNAMEN1CYP3A4ALOX15KMT2A
SCHEMBL21895839 0.87 LMNA (0.46) LMNAMEN1CYP3A4ALOX15KMT2A
SCHEMBL11253033 0.84 LMNA (0.39) LMNAMEN1CYP3A4ALOX15KMT2A
SCHEMBL2849610 0.84 LMNA (0.39) LMNAMEN1CYP3A4ALOX15KMT2A
SCHEMBL30446996 0.82 LMNA (0.45) LMNAMEN1CYP3A4ALOX15KMT2A
SCHEMBL19192131 0.81 LMNA (0.35) LMNAMEN1CYP3A4ALOX15KMT2A
SCHEMBL4027594 0.80 ACE2 (0.46) LMNAMEN1CYP3A4ALOX15KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 142 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111164149-B Inverse emulsion thickener 斯科特贝德有限公司 2022-05-24 CN claimed
US-11248093-B2 Inverse emulsion thickeners SCOTT BADER COMPANY LTD. (GB) 2022-02-15 US claimed
US-11193078-B2 Olefins and methods for making the same Amyris, Inc. (US) 2021-12-07 US claimed
EP-3692096-B1 INVERSE EMULSION THICKENERS SCOTT BADER CO (GB) 2021-12-01 EP claimed
CN-112898661-A Antibacterial and antiviral composite material for automobile steering wheel 宇豪(马鞍山)科技有限公司 2021-06-04 CN claimed
EP-3692096-A1 INVERSE EMULSION THICKENERS Scott Bader Company Ltd (GB) 2020-08-12 EP claimed
US-20200231762-A1 INVERSE EMULSION THICKENERS SCOTT BADER COMPANY LTD (GB) 2020-07-23 US claimed
CN-111164149-A Inverse emulsion thickener 斯科特贝德有限公司 2020-05-15 CN claimed
EP-2697187-B1 OLEFINS AND METHODS FOR MAKING THE SAME AMYRIS INC (US) 2020-04-22 EP claimed
US-20190249101-A1 OLEFINS AND METHODS FOR MAKING THE SAME EUAGORE, LLC 2019-08-15 US claimed
EP-3137047-B1 SOLVENT COMPOSITIONS BASED ON DIHYDROFARNESENE AMYRIS INC (US) 2019-06-26 EP claimed
US-10294439-B2 Olefins and methods for making the same Amyris, Inc. (US) 2019-05-21 US claimed
WO-2019068830-A1 INVERSE EMULSION THICKENERS SCOTT BADER COMPANY LTD (GB) 2019-04-11 WO claimed
US-10071034-B2 Solvent compositions Amyris, Inc. (US) 2018-09-11 US claimed
EP-3209630-A1 SELECTIVE PARTIAL HYDROGENATION OF BETA-FARNESENE Novvi LLC (US) 2017-08-30 EP claimed
CN-106456471-A Dihydrophenanthrene-based solvent compositions 爱美瑞公司 2017-02-22 CN claimed
US-20150315520-A1 SOLVENT COMPOSITIONS EUAGORE, LLC 2015-11-05 US claimed
US-20140148624-A1 OLEFINS AND METHODS FOR MAKING THE SAME Amyris, Inc. (US) 2014-05-29 US claimed
EP-2697187-A1 OLEFINS AND METHODS FOR MAKING THE SAME Amyris, Inc. (US) 2014-02-19 EP claimed
WO-2012141783-A1 OLEFINS AND METHODS FOR MAKING THE SAME Amyris, Inc. (US) 2012-10-18 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190249101-A1 OLEFINS AND METHODS FOR MAKING THE SAME HSD17B10, DHCR7, HSD17B12 LMNA 2495/4885MEN1 2665/4885CYP3A4 118/4885
US-11193078-B2 Olefins and methods for making the same HSD17B10, DHCR7, HSD17B12 LMNA 2495/4885MEN1 2665/4885CYP3A4 118/4885
US-20150315520-A1 SOLVENT COMPOSITIONS DHCR24, HRAS, KRAS LMNA 2946/4885MEN1 522/4885CYP3A4 1813/4885
US-20140148624-A1 OLEFINS AND METHODS FOR MAKING THE SAME HSD17B10, DHCR7, HSD17B12 LMNA 2495/4885MEN1 2665/4885CYP3A4 118/4885
US-10294439-B2 Olefins and methods for making the same HSD17B10, DHCR7, HSD17B12 LMNA 2495/4885MEN1 2665/4885CYP3A4 118/4885
US-10071034-B2 Solvent compositions DHCR24, HRAS, KRAS LMNA 2946/4885MEN1 522/4885CYP3A4 1813/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.